Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-009840

CEO sold 25,350 shares at an average $84.95 ($2,153,373)

  • CEO acquired 25,350 shares (option exercise)
  • CEO gave 3,863 shares (gift)
  • CEO gave 3,863 shares (gift)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Zovighian Bernard J · CEO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-08 Exercise or conversion : show line 1 in the form 10b5-1 +25,350 $59.26 $1,502,157 106,326 D
2025-12-08 Sale : show line 2 in the form 10b5-1 −21,487 $85.21 $1,831,006 84,839 D
2025-12-09 Gift : show line 3 in the form 10b5-1 −3,863 80,976 D
2025-12-09 Gift : show line 4 in the form 10b5-1 +3,863 12,459.55 I
2025-12-10 Sale : show line 5 in the form 10b5-1 −3,863 $83.45 $322,367 8,596.55 I
Open-market sales · 25,350 sh · avg $84.95 · $2,153,373

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-08 Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (Right to Acquire) −25,350 25,350 D
Loading xslF345X05/doc4.xml…